Higher Time to Peak after Stent Implantation in Symptomatic High-Grade Intracranial Atherosclerotic Stenosis is Related to In-Stent Restenosis

Little is known about the association between periprocedural hemodynamics and in-stent restenosis (ISR) following stent implantation in patients with symptomatic intracranial atherosclerotic stenosis (ICAS). This study aims to identify periprocedural hemodynamics that may be associated with ISR. Sub...

Full description

Saved in:
Bibliographic Details
Published inTranslational stroke research Vol. 16; no. 5; pp. 1756 - 1765
Main Authors Zhang, Longhui, Zhu, Haoyu, Zhang, Yupeng, Chen, Fangguang, Sun, Dapeng, Liu, Yufan, Jiang, Chuhan, Miao, Zhongrong, Jia, Baixue
Format Journal Article
LanguageEnglish
Published New York Springer US 01.10.2025
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN1868-4483
1868-601X
1868-601X
DOI10.1007/s12975-025-01346-0

Cover

Loading…
Abstract Little is known about the association between periprocedural hemodynamics and in-stent restenosis (ISR) following stent implantation in patients with symptomatic intracranial atherosclerotic stenosis (ICAS). This study aims to identify periprocedural hemodynamics that may be associated with ISR. Subjects were selected from the NOVA trial (The First-in-man Trial Evaluating the Safety and Efficacy of the NOVA Intracranial Stent Trial). ISR was defined as greater than 50% stenosis of the luminal diameter within or immediately adjacent to (within 5 mm) the implanted stent. Periprocedural hemodynamics, including cerebral blood flow, cerebral blood volume, mean transit time, and time to peak (TTP), were derived from the time-density curve generated from digital subtraction angiography using the fast Fourier transform algorithm. Of the 263 patients enrolled in the NOVA trial, 176 with symptomatic high-grade ICAS who underwent stent implantation were included in this study. Of these, 35 (19.9%) were diagnosed with ISR at the one-year follow-up. No significant differences in pre-procedure hemodynamics were observed between stent groups and between the ISR groups and the non-ISR group. Higher post-procedure TTP (OR, 1.95; 95% CI, 1.26–3.02), the use of bare-metal stents (OR, 5.40; 95% CI, 2.21–13.19), and higher post-procedure residual stenosis (OR, 1.08; 95% CI, 1.03–1.13) were independent factors associated with ISR. Higher post-procedure TTP, the use of bare-metal stents, and higher post-procedure residual stenosis were independent factors associated with ISR. The combined use of periprocedural hemodynamics and clinical factors may help predict ISR in patients with symptomatic high-grade ICAS. Graphical Abstract
AbstractList Little is known about the association between periprocedural hemodynamics and in-stent restenosis (ISR) following stent implantation in patients with symptomatic intracranial atherosclerotic stenosis (ICAS). This study aims to identify periprocedural hemodynamics that may be associated with ISR. Subjects were selected from the NOVA trial (The First-in-man Trial Evaluating the Safety and Efficacy of the NOVA Intracranial Stent Trial). ISR was defined as greater than 50% stenosis of the luminal diameter within or immediately adjacent to (within 5 mm) the implanted stent. Periprocedural hemodynamics, including cerebral blood flow, cerebral blood volume, mean transit time, and time to peak (TTP), were derived from the time-density curve generated from digital subtraction angiography using the fast Fourier transform algorithm. Of the 263 patients enrolled in the NOVA trial, 176 with symptomatic high-grade ICAS who underwent stent implantation were included in this study. Of these, 35 (19.9%) were diagnosed with ISR at the one-year follow-up. No significant differences in pre-procedure hemodynamics were observed between stent groups and between the ISR groups and the non-ISR group. Higher post-procedure TTP (OR, 1.95; 95% CI, 1.26–3.02), the use of bare-metal stents (OR, 5.40; 95% CI, 2.21–13.19), and higher post-procedure residual stenosis (OR, 1.08; 95% CI, 1.03–1.13) were independent factors associated with ISR. Higher post-procedure TTP, the use of bare-metal stents, and higher post-procedure residual stenosis were independent factors associated with ISR. The combined use of periprocedural hemodynamics and clinical factors may help predict ISR in patients with symptomatic high-grade ICAS.
Little is known about the association between periprocedural hemodynamics and in-stent restenosis (ISR) following stent implantation in patients with symptomatic intracranial atherosclerotic stenosis (ICAS). This study aims to identify periprocedural hemodynamics that may be associated with ISR. Subjects were selected from the NOVA trial (The First-in-man Trial Evaluating the Safety and Efficacy of the NOVA Intracranial Stent Trial). ISR was defined as greater than 50% stenosis of the luminal diameter within or immediately adjacent to (within 5 mm) the implanted stent. Periprocedural hemodynamics, including cerebral blood flow, cerebral blood volume, mean transit time, and time to peak (TTP), were derived from the time-density curve generated from digital subtraction angiography using the fast Fourier transform algorithm. Of the 263 patients enrolled in the NOVA trial, 176 with symptomatic high-grade ICAS who underwent stent implantation were included in this study. Of these, 35 (19.9%) were diagnosed with ISR at the one-year follow-up. No significant differences in pre-procedure hemodynamics were observed between stent groups and between the ISR groups and the non-ISR group. Higher post-procedure TTP (OR, 1.95; 95% CI, 1.26-3.02), the use of bare-metal stents (OR, 5.40; 95% CI, 2.21-13.19), and higher post-procedure residual stenosis (OR, 1.08; 95% CI, 1.03-1.13) were independent factors associated with ISR. Higher post-procedure TTP, the use of bare-metal stents, and higher post-procedure residual stenosis were independent factors associated with ISR. The combined use of periprocedural hemodynamics and clinical factors may help predict ISR in patients with symptomatic high-grade ICAS.
Little is known about the association between periprocedural hemodynamics and in-stent restenosis (ISR) following stent implantation in patients with symptomatic intracranial atherosclerotic stenosis (ICAS). This study aims to identify periprocedural hemodynamics that may be associated with ISR. Subjects were selected from the NOVA trial (The First-in-man Trial Evaluating the Safety and Efficacy of the NOVA Intracranial Stent Trial). ISR was defined as greater than 50% stenosis of the luminal diameter within or immediately adjacent to (within 5 mm) the implanted stent. Periprocedural hemodynamics, including cerebral blood flow, cerebral blood volume, mean transit time, and time to peak (TTP), were derived from the time-density curve generated from digital subtraction angiography using the fast Fourier transform algorithm. Of the 263 patients enrolled in the NOVA trial, 176 with symptomatic high-grade ICAS who underwent stent implantation were included in this study. Of these, 35 (19.9%) were diagnosed with ISR at the one-year follow-up. No significant differences in pre-procedure hemodynamics were observed between stent groups and between the ISR groups and the non-ISR group. Higher post-procedure TTP (OR, 1.95; 95% CI, 1.26–3.02), the use of bare-metal stents (OR, 5.40; 95% CI, 2.21–13.19), and higher post-procedure residual stenosis (OR, 1.08; 95% CI, 1.03–1.13) were independent factors associated with ISR. Higher post-procedure TTP, the use of bare-metal stents, and higher post-procedure residual stenosis were independent factors associated with ISR. The combined use of periprocedural hemodynamics and clinical factors may help predict ISR in patients with symptomatic high-grade ICAS. Graphical Abstract
Little is known about the association between periprocedural hemodynamics and in-stent restenosis (ISR) following stent implantation in patients with symptomatic intracranial atherosclerotic stenosis (ICAS). This study aims to identify periprocedural hemodynamics that may be associated with ISR. Subjects were selected from the NOVA trial (The First-in-man Trial Evaluating the Safety and Efficacy of the NOVA Intracranial Stent Trial). ISR was defined as greater than 50% stenosis of the luminal diameter within or immediately adjacent to (within 5 mm) the implanted stent. Periprocedural hemodynamics, including cerebral blood flow, cerebral blood volume, mean transit time, and time to peak (TTP), were derived from the time-density curve generated from digital subtraction angiography using the fast Fourier transform algorithm. Of the 263 patients enrolled in the NOVA trial, 176 with symptomatic high-grade ICAS who underwent stent implantation were included in this study. Of these, 35 (19.9%) were diagnosed with ISR at the one-year follow-up. No significant differences in pre-procedure hemodynamics were observed between stent groups and between the ISR groups and the non-ISR group. Higher post-procedure TTP (OR, 1.95; 95% CI, 1.26-3.02), the use of bare-metal stents (OR, 5.40; 95% CI, 2.21-13.19), and higher post-procedure residual stenosis (OR, 1.08; 95% CI, 1.03-1.13) were independent factors associated with ISR. Higher post-procedure TTP, the use of bare-metal stents, and higher post-procedure residual stenosis were independent factors associated with ISR. The combined use of periprocedural hemodynamics and clinical factors may help predict ISR in patients with symptomatic high-grade ICAS.Little is known about the association between periprocedural hemodynamics and in-stent restenosis (ISR) following stent implantation in patients with symptomatic intracranial atherosclerotic stenosis (ICAS). This study aims to identify periprocedural hemodynamics that may be associated with ISR. Subjects were selected from the NOVA trial (The First-in-man Trial Evaluating the Safety and Efficacy of the NOVA Intracranial Stent Trial). ISR was defined as greater than 50% stenosis of the luminal diameter within or immediately adjacent to (within 5 mm) the implanted stent. Periprocedural hemodynamics, including cerebral blood flow, cerebral blood volume, mean transit time, and time to peak (TTP), were derived from the time-density curve generated from digital subtraction angiography using the fast Fourier transform algorithm. Of the 263 patients enrolled in the NOVA trial, 176 with symptomatic high-grade ICAS who underwent stent implantation were included in this study. Of these, 35 (19.9%) were diagnosed with ISR at the one-year follow-up. No significant differences in pre-procedure hemodynamics were observed between stent groups and between the ISR groups and the non-ISR group. Higher post-procedure TTP (OR, 1.95; 95% CI, 1.26-3.02), the use of bare-metal stents (OR, 5.40; 95% CI, 2.21-13.19), and higher post-procedure residual stenosis (OR, 1.08; 95% CI, 1.03-1.13) were independent factors associated with ISR. Higher post-procedure TTP, the use of bare-metal stents, and higher post-procedure residual stenosis were independent factors associated with ISR. The combined use of periprocedural hemodynamics and clinical factors may help predict ISR in patients with symptomatic high-grade ICAS.
Author Zhang, Yupeng
Miao, Zhongrong
Chen, Fangguang
Sun, Dapeng
Jia, Baixue
Liu, Yufan
Zhu, Haoyu
Zhang, Longhui
Jiang, Chuhan
Author_xml – sequence: 1
  givenname: Longhui
  surname: Zhang
  fullname: Zhang, Longhui
  organization: Interventional Neuroradiology Department, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University
– sequence: 2
  givenname: Haoyu
  surname: Zhu
  fullname: Zhu, Haoyu
  organization: Department of Neurosurgery, Beijing Neurosurgical Institute and Beijing Tiantan Hospital, Capital Medical University, Department of Neurosurgery, Peking University First Hospital
– sequence: 3
  givenname: Yupeng
  surname: Zhang
  fullname: Zhang, Yupeng
  organization: Department of Neurosurgery, Beijing Neurosurgical Institute and Beijing Tiantan Hospital, Capital Medical University
– sequence: 4
  givenname: Fangguang
  surname: Chen
  fullname: Chen, Fangguang
  organization: Interventional Neuroradiology Department, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University
– sequence: 5
  givenname: Dapeng
  surname: Sun
  fullname: Sun, Dapeng
  organization: Interventional Neuroradiology Department, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University
– sequence: 6
  givenname: Yufan
  surname: Liu
  fullname: Liu, Yufan
  organization: China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University
– sequence: 7
  givenname: Chuhan
  surname: Jiang
  fullname: Jiang, Chuhan
  organization: Department of Neurosurgery, Beijing Neurosurgical Institute and Beijing Tiantan Hospital, Capital Medical University
– sequence: 8
  givenname: Zhongrong
  surname: Miao
  fullname: Miao, Zhongrong
  email: zhongrongm@163.com
  organization: Interventional Neuroradiology Department, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University
– sequence: 9
  givenname: Baixue
  surname: Jia
  fullname: Jia, Baixue
  email: beckyberry@163.com
  organization: Interventional Neuroradiology Department, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40120037$$D View this record in MEDLINE/PubMed
BookMark eNp9kctu1DAUhi3UipbSF2CBLLFhE-pbHM-yqqAdqRJVWyR2lsc5LimJPdieRV-CZ-aEDCCxqOW7vv8c-_yvyEFMEQh5w9kHzlh3VrhYdW3DBA4ulW7YC3LMjTaNZvzrwX6vlJFH5LSUR4ZNcqWVfEmOFOMCj90x-Xk1PHyDTO-HCWhN9Abcd-pCxau7CrHS9bQdXayuDinSIdK7p2lb04RnT2dtc5ldD3Qda3Y-uzi4kZ5XDJmKH3GeuTlSKkOh2G9hdBX6Odc6NkuOWyh74jU5DG4scLpfT8iXTx_vL66a68-X64vz68aLVtemcz60fb8SoIN3TMDK6WA0qKC52PTcO1CgnGlBtBveMWiFElrIjeyVMSHIE_J-ibvN6ccO09tpKB5G_CqkXbGSG6ZNq41E9N1_6GPa5Yivs1IohSWVLUfq7Z7abSbo7TYPk8tP9k-lERAL4LEyJUP4i3BmZ0ft4qhFR-1vRy1DkVxEBeH4APlf7mdUvwBAIKQH
Cites_doi 10.1161/STROKEAHA.119.025537
10.1177/0284185114538793
10.1136/neurintsurg-2017-013259
10.1161/STROKEAHA.116.014537
10.1093/cvr/cvt115
10.1136/neurintsurg-2021-018187
10.1001/jamaneurol.2015.3145
10.1001/jamaneurol.2021.4804
10.1001/jama.2022.12000
10.1002/jcp.29955
10.1002/acn3.51718
10.1038/s41598-021-89670-x
10.3389/fneur.2023.1136847
10.1016/S0735-1097(97)00450-6
10.1038/nrcardio.2011.132
10.1007/s00330-023-10209-x
10.1212/WNL.0000000000003534
10.1161/STROKEAHA.115.010549
10.3389/fneur.2023.1170110
10.3174/ajnr.A4698
10.1093/cvr/cvt061
10.1161/STR.0000000000000375
10.1161/STROKEAHA.113.001824
10.1161/STROKEAHA.118.023996
10.3174/ajnr.A4813
10.3174/ajnr.A6689
10.1161/STROKEAHA.108.522391
10.1161/01.CIR.0000019071.72887.BD
10.1177/0271678X221086408
10.1056/NEJMoa1105335
10.1007/s00401-015-1524-y
10.1161/STROKEAHA.123.045456
10.1161/CIRCRESAHA.116.308441
10.3174/ajnr.A0869
10.1186/1479-5876-7-97
10.1161/STROKEAHA.121.035850
10.3174/ajnr.A3049
10.1093/cvr/cvt090
10.1001/jamaneurol.2015.4315
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2025 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2025.
Copyright_xml – notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2025 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
– notice: 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
– notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2025.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
DOI 10.1007/s12975-025-01346-0
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)
MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1868-601X
EndPage 1765
ExternalDocumentID 40120037
10_1007_s12975_025_01346_0
Genre Journal Article
GrantInformation_xml – fundername: the Natural Science Foundation of Beijing Municipality
  grantid: 7212007
– fundername: National Natural Science Foundation of China
  grantid: 82401538
  funderid: https://doi.org/10.13039/501100001809
– fundername: National Natural Science Foundation of China
  grantid: 82401538
GroupedDBID ---
06C
06D
0R~
0VY
1N0
203
29~
2JY
2VQ
30V
4.4
406
408
409
40D
53G
67N
7X7
875
8FI
8FJ
96X
AAAVM
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
AAZMS
ABAKF
ABBRH
ABBXA
ABDBE
ABDZT
ABECU
ABFSG
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKCH
ABMQK
ABPLI
ABQBU
ABRTQ
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACDTI
ACGFS
ACHSB
ACKNC
ACMLO
ACOKC
ACPIV
ACSTC
ACZOJ
ADHHG
ADHIR
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETCA
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFHIU
AFKRA
AFLOW
AFOHR
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGWZB
AGYKE
AHAVH
AHBYD
AHPBZ
AHSBF
AHWEU
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AIXLP
AJBLW
AJRNO
AJZVZ
AKLTO
AKMHD
ALFXC
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMXSW
AMYLF
AMYQR
ANMIH
ASPBG
ATHPR
AUKKA
AVWKF
AXYYD
AYFIA
AZFZN
BENPR
BGNMA
CCPQU
CSCUP
DNIVK
DPUIP
EBLON
EBS
EIOEI
EJD
EN4
ESBYG
F5P
FEDTE
FERAY
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FYJPI
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GQ7
GQ8
H13
HF~
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I0C
IKXTQ
IWAJR
IXD
IZIGR
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KOV
LLZTM
M4Y
NPVJJ
NQJWS
NU0
O9-
O93
O9I
O9J
PHGZM
PHGZT
PSYQQ
PT4
PUEGO
QOR
QOS
R89
R9I
RLLFE
ROL
RSV
S27
S3A
S3B
SBL
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
T13
TSG
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VFIZW
W48
WK8
Z45
ZMTXR
ZOVNA
~A9
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
ID FETCH-LOGICAL-c256t-7acf5dd92e6fca02e9a6f86e4f612bd1cae4e4a85e25b170e5242623b3d488ff3
IEDL.DBID U2A
ISSN 1868-4483
1868-601X
IngestDate Fri Jul 11 03:40:48 EDT 2025
Fri Aug 29 04:51:55 EDT 2025
Wed Sep 03 02:27:43 EDT 2025
Wed Sep 03 16:34:21 EDT 2025
Thu Aug 28 04:24:34 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords In-stent restenosis
Hemodynamics
Drug-eluting stents
Intracranial atherosclerotic stenosis
Language English
License 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c256t-7acf5dd92e6fca02e9a6f86e4f612bd1cae4e4a85e25b170e5242623b3d488ff3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 40120037
PQID 3244146351
PQPubID 6623311
PageCount 10
ParticipantIDs proquest_miscellaneous_3180685683
proquest_journals_3244146351
pubmed_primary_40120037
crossref_primary_10_1007_s12975_025_01346_0
springer_journals_10_1007_s12975_025_01346_0
PublicationCentury 2000
PublicationDate 20251000
PublicationDateYYYYMMDD 2025-10-01
PublicationDate_xml – month: 10
  year: 2025
  text: 20251000
PublicationDecade 2020
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: United States
PublicationTitle Translational stroke research
PublicationTitleAbbrev Transl. Stroke Res
PublicationTitleAlternate Transl Stroke Res
PublicationYear 2025
Publisher Springer US
Springer Nature B.V
Publisher_xml – name: Springer US
– name: Springer Nature B.V
References K Huang (1346_CR24) 2023; 34
S Prabhakaran (1346_CR18) 2009; 40
X Song (1346_CR31) 2023; 14
K Thiankhaw (1346_CR34) 2021; 236
N Wang (1346_CR12) 2023; 14
SE Lakhan (1346_CR32) 2009; 7
B Jia (1346_CR14) 2022; 79
Z Li (1346_CR22) 2022; 14
K Zhang (1346_CR16) 2021; 11
CJ Lin (1346_CR19) 2012; 33
C Chaabane (1346_CR41) 2013; 99
JC Kosior (1346_CR21) 2019; 50
OB Samuels (1346_CR25) 2000; 21
MF Waters (1346_CR4) 2016; 73
DO Kleindorfer (1346_CR2) 2021; 52
Z Miao (1346_CR6) 2015; 46
MJ Alexander (1346_CR7) 2019; 50
P Gao (1346_CR9) 2022; 328
TN Turan (1346_CR5) 2017; 88
MMH Teng (1346_CR39) 2016; 37
CP Derdeyn (1346_CR11) 2017; 48
C Zhang (1346_CR28) 2013; 99
P Gao (1346_CR8) 2016; 37
YJ Wang (1346_CR38) 2023; 10
AS Turk (1346_CR17) 2008; 29
A Farb (1346_CR35) 2002; 105
HM Kwon (1346_CR27) 2016; 73
K Van der Heiden (1346_CR30) 2013; 99
JW Jukema (1346_CR37) 2011; 9
Y Zhang (1346_CR23) 2022; 42
G Peng (1346_CR13) 2020; 41
K Yamauchi (1346_CR20) 2018; 10
MI Chimowitz (1346_CR3) 2011; 365
Y Yu (1346_CR15) 2021; 136
R Kornowski (1346_CR36) 1998; 31
M Jin (1346_CR10) 2013; 44
AJS Webb (1346_CR29) 2022; 53
Y Zhang (1346_CR26) 2024; 55
N Dudvarski Stankovic (1346_CR33) 2016; 131
C Banerjee (1346_CR1) 2017; 120
XQ Cheng (1346_CR40) 2015; 56
References_xml – volume: 50
  start-page: 2389
  issue: 9
  year: 2019
  ident: 1346_CR21
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.119.025537
– volume: 56
  start-page: 754
  issue: 6
  year: 2015
  ident: 1346_CR40
  publication-title: Acta Radiol
  doi: 10.1177/0284185114538793
– volume: 10
  start-page: 576
  issue: 6
  year: 2018
  ident: 1346_CR20
  publication-title: J Neurointerv Surg
  doi: 10.1136/neurintsurg-2017-013259
– volume: 48
  start-page: 1501
  issue: 6
  year: 2017
  ident: 1346_CR11
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.116.014537
– volume: 99
  start-page: 353
  issue: 2
  year: 2013
  ident: 1346_CR41
  publication-title: Cardiovasc Res
  doi: 10.1093/cvr/cvt115
– volume: 14
  start-page: 1112
  issue: 11
  year: 2022
  ident: 1346_CR22
  publication-title: J Neurointerv Surg
  doi: 10.1136/neurintsurg-2021-018187
– volume: 73
  start-page: 36
  issue: 1
  year: 2016
  ident: 1346_CR27
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2015.3145
– volume: 79
  start-page: 176
  issue: 2
  year: 2022
  ident: 1346_CR14
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2021.4804
– volume: 328
  start-page: 534
  issue: 6
  year: 2022
  ident: 1346_CR9
  publication-title: JAMA
  doi: 10.1001/jama.2022.12000
– volume: 236
  start-page: 1677
  issue: 3
  year: 2021
  ident: 1346_CR34
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.29955
– volume: 10
  start-page: 266
  issue: 2
  year: 2023
  ident: 1346_CR38
  publication-title: Ann Clin Transl Neurol
  doi: 10.1002/acn3.51718
– volume: 11
  start-page: 10479
  issue: 1
  year: 2021
  ident: 1346_CR16
  publication-title: Sci Rep
  doi: 10.1038/s41598-021-89670-x
– volume: 14
  start-page: 1136847
  year: 2023
  ident: 1346_CR31
  publication-title: Front Neurol
  doi: 10.3389/fneur.2023.1136847
– volume: 31
  start-page: 224
  issue: 1
  year: 1998
  ident: 1346_CR36
  publication-title: J Am Coll Cardiol
  doi: 10.1016/S0735-1097(97)00450-6
– volume: 9
  start-page: 53
  issue: 1
  year: 2011
  ident: 1346_CR37
  publication-title: Nat Rev Cardiol
  doi: 10.1038/nrcardio.2011.132
– volume: 136
  start-page: 1
  year: 2021
  ident: 1346_CR15
  publication-title: J Neurosurg
– volume: 34
  start-page: 2352
  year: 2023
  ident: 1346_CR24
  publication-title: Eur Radiol
  doi: 10.1007/s00330-023-10209-x
– volume: 88
  start-page: 379
  issue: 4
  year: 2017
  ident: 1346_CR5
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000003534
– volume: 46
  start-page: 2822
  issue: 10
  year: 2015
  ident: 1346_CR6
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.115.010549
– volume: 14
  start-page: 1170110
  year: 2023
  ident: 1346_CR12
  publication-title: Front Neurol
  doi: 10.3389/fneur.2023.1170110
– volume: 37
  start-page: 1275
  issue: 7
  year: 2016
  ident: 1346_CR8
  publication-title: AJNR Am J Neuroradiol
  doi: 10.3174/ajnr.A4698
– volume: 99
  start-page: 251
  issue: 2
  year: 2013
  ident: 1346_CR28
  publication-title: Cardiovasc Res
  doi: 10.1093/cvr/cvt061
– volume: 52
  start-page: e364
  issue: 7
  year: 2021
  ident: 1346_CR2
  publication-title: Stroke
  doi: 10.1161/STR.0000000000000375
– volume: 44
  start-page: 2990
  issue: 11
  year: 2013
  ident: 1346_CR10
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.113.001824
– volume: 50
  start-page: 889
  issue: 4
  year: 2019
  ident: 1346_CR7
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.118.023996
– volume: 37
  start-page: 1883
  issue: 10
  year: 2016
  ident: 1346_CR39
  publication-title: AJNR Am J Neuroradiol
  doi: 10.3174/ajnr.A4813
– volume: 41
  start-page: 1447
  issue: 8
  year: 2020
  ident: 1346_CR13
  publication-title: AJNR Am J Neuroradiol
  doi: 10.3174/ajnr.A6689
– volume: 40
  start-page: 991
  issue: 3
  year: 2009
  ident: 1346_CR18
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.108.522391
– volume: 105
  start-page: 2974
  issue: 25
  year: 2002
  ident: 1346_CR35
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000019071.72887.BD
– volume: 42
  start-page: 1524
  issue: 8
  year: 2022
  ident: 1346_CR23
  publication-title: J Cereb Blood Flow Metab
  doi: 10.1177/0271678X221086408
– volume: 365
  start-page: 993
  issue: 11
  year: 2011
  ident: 1346_CR3
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1105335
– volume: 131
  start-page: 347
  issue: 3
  year: 2016
  ident: 1346_CR33
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-015-1524-y
– volume: 21
  start-page: 643
  issue: 4
  year: 2000
  ident: 1346_CR25
  publication-title: AJNR Am J Neuroradiol
– volume: 55
  start-page: 1339
  issue: 5
  year: 2024
  ident: 1346_CR26
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.123.045456
– volume: 120
  start-page: 502
  issue: 3
  year: 2017
  ident: 1346_CR1
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.116.308441
– volume: 29
  start-page: 23
  issue: 1
  year: 2008
  ident: 1346_CR17
  publication-title: AJNR Am J Neuroradiol
  doi: 10.3174/ajnr.A0869
– volume: 7
  start-page: 97
  year: 2009
  ident: 1346_CR32
  publication-title: J Transl Med
  doi: 10.1186/1479-5876-7-97
– volume: 53
  start-page: 1054
  issue: 4
  year: 2022
  ident: 1346_CR29
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.121.035850
– volume: 33
  start-page: 1685
  issue: 9
  year: 2012
  ident: 1346_CR19
  publication-title: AJNR Am J Neuroradiol
  doi: 10.3174/ajnr.A3049
– volume: 99
  start-page: 269
  issue: 2
  year: 2013
  ident: 1346_CR30
  publication-title: Cardiovasc Res
  doi: 10.1093/cvr/cvt090
– volume: 73
  start-page: 308
  issue: 3
  year: 2016
  ident: 1346_CR4
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2015.4315
SSID ssj0000314643
Score 2.3643224
Snippet Little is known about the association between periprocedural hemodynamics and in-stent restenosis (ISR) following stent implantation in patients with...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Publisher
StartPage 1756
SubjectTerms Aged
Angiography, Digital Subtraction
Atherosclerosis
Biomedical and Life Sciences
Biomedicine
Blood
Cardiology
Cerebrovascular Circulation - physiology
Constriction, Pathologic - surgery
Female
Fourier transforms
Hemodynamics
Hemodynamics - physiology
Humans
Intracranial Arteriosclerosis - diagnostic imaging
Intracranial Arteriosclerosis - physiopathology
Intracranial Arteriosclerosis - surgery
Ischemia
Male
Medical imaging
Middle Aged
Neurology
Neurosciences
Neurosurgery
Patients
Risk factors
Stents
Stents - adverse effects
Stroke
Time Factors
Transient ischemic attack
Vascular Surgery
Veins & arteries
Title Higher Time to Peak after Stent Implantation in Symptomatic High-Grade Intracranial Atherosclerotic Stenosis is Related to In-Stent Restenosis
URI https://link.springer.com/article/10.1007/s12975-025-01346-0
https://www.ncbi.nlm.nih.gov/pubmed/40120037
https://www.proquest.com/docview/3244146351
https://www.proquest.com/docview/3180685683
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEB7aBEovpY-0dZoEBXprBLZe1h6XkldLcmi6kJ6MbEuwhNhh7Rz6J_qbMyPbu5Q0h4JvHmuMR-P5pJlvBPBZ5xhXaqF4bbLAlRQzPkvRr6wM1lYE6XMiCl9cmrOF-natr0dSWDdVu08pyfin3pDdiATK6fhVhC0K18HPYVvT2h1n8ULM1zsr1JDdDJX11liO6w85smX-PczfEekRzHyUIo2R5-Q1vBohI5sPNn4Dz3zzFl5cjEnxd_BnqNVgxOZgfcvwL3fD4tnf7AoRcc-oA7AbKEYNWzbs6vftXd_GXq2MnuWnK1d7dk77vBXGriVpI2DYdqhw1ZIcjdR2y47hFQvofE26zhs-6PhB-6ZRYgcWJ8c_v57x8ZgFXiHe6XnuqqDreia8CZVLhZ85E6zxKiD6Keuscl555az2QpdZnnpNYV3IUtbo_SHI97DVtI3_CCwvc5VWVgkVgqq8Ko3LSwQlivoeuswn8GX61MXd0E2j2PRNJsMUaJgiGqZIE9ibrFGMntUVCAAV2lfqLIHD9W30CUp0uMa39yiT2dRYbaxM4MNgxbU6RWzhVOYJHE1m3Qz-9Lvs_p_4J3gpaIrFqr892OpX934f0UtfHsD2_PTX9-ODOGkfAMcb5o4
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1NT9wwEB1RkNpeKugHTUtbI3FrLSW243iPCEF3KcuhsBK3yElsaYVI0CYc-if6mzvjJLtCtIdKuWXiiTIez4tn3hjgKM0wrlRC8UonnispJnwSo18Z6Y0pCdJnRBSeX-rpQp3fpDcDKawdq93HlGRYqTdkNyKBcjp-FWGLwv_gZ7CDYMBQIddCHK93Vqghu-4r6402HP8_5MCW-fswjyPSE5j5JEUaIs_ZLrwaICM77m28B1uufg3P50NS_A387ms1GLE5WNcwXOVuWTj7m10hIu4YdQC2PcWoZsuaXf26u--a0KuV0bP8-8pWjs1on7fE2LUkbQQMmxYVrhqSo5GadtkyvEIBnatI16zmvY6ftG8aJN7C4uz0-mTKh2MWeIl4p-OZLX1aVRPhtC9tLNzEam-0Ux7RT1ElpXXKKWtSJ9IiyWKXUlgXspAVer_38h1s103t3gPLikzFpVFCea9KpwptswJBiaK-hzZxEXwdP3V-33fTyDd9k8kwORomD4bJ4wgORmvkg2e1OQJAhfaVaRLB4fo2-gQlOmztmgeUSUysTaqNjGC_t-JanSK2cCyzCL6NZt0M_u93-fB_4l_gxfR6fpFfzC5_fISXgqZbqAA8gO1u9eA-IZLpis9h4v4BjoDn7Q
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Nb9QwEB2VVqq4IGj5SCnUSL2B1cR2HO-xApYu0KpqWam3yIltaYVIVrvpoX-C38yMk90FFQ5IuWXiSTK259kzbwxwnBfoV5xQ3OkscCXFiI9SHFdGBmNqgvQFEYXPL_TZVH2-yW9-Y_HHbPdVSLLnNFCVpqY7mbtwsiG-ESGU01GsCGEUrokfwA5Oxxn166k4Xe-yUHF23WfZG204rkXkwJz5ezN_eqd7kPNeuDR6ofFjeDTAR3ba2_sJbPlmD3bPhwD5Pvzs8zYYMTtY1zKc8b6zeA44u6bvY1QN2PZ0o4bNGnZ992PetbFuK6Nn-aeFdZ5NaM-3Rj82I20EEtslKly0JEcttcvZkuEVk-m8I12Thvc6rmgPNUo8hen447f3Z3w4coHXiH06Xtg65M6NhNehtqnwI6uD0V4FREKVy2rrlVfW5F7kVVakPicXL2QlHc4EIchnsN20jX8BrKgKldZGCRWCqr2qtC0qBCiKaiDazCfwdvWry3lfWaPc1FAmw5RomDIapkwTOFxZoxxG2bJEMKjQvjLPEnizvo3jg4IetvHtLcpkJtUm10Ym8Ly34lqdIuZwKosE3q3Mumn83-9y8H_iR7B7-WFcfp1cfHkJDwX1tpgMeAjb3eLWv0JQ01WvY7_9Bfgg7Ck
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Higher+Time+to+Peak+after+Stent+Implantation+in+Symptomatic+High-Grade+Intracranial+Atherosclerotic+Stenosis+is+Related+to+In-Stent+Restenosis&rft.jtitle=Translational+stroke+research&rft.au=Zhang%2C+Longhui&rft.au=Zhu%2C+Haoyu&rft.au=Zhang%2C+Yupeng&rft.au=Chen%2C+Fangguang&rft.date=2025-10-01&rft.pub=Springer+Nature+B.V&rft.issn=1868-4483&rft.eissn=1868-601X&rft.volume=16&rft.issue=5&rft.spage=1756&rft.epage=1765&rft_id=info:doi/10.1007%2Fs12975-025-01346-0&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1868-4483&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1868-4483&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1868-4483&client=summon